Last updated at 02 Jul 2024 09:44 AM
Director
DIN: 05318863
Mandiyan Basheer . is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at ADAM AND EVE HEALTH SOLUTIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05318863.Mandiyan Basheer . is currently involved in 2 different roles. Their most recent position is with AISHAL MEDICITY PRIVATE LIMITED as a Individual Promoter. The first company Mandiyan Basheer . was appointed to as a director was ADAM AND EVE HEALTH SOLUTIONS PRIVATE LIMITED. Mandiyan Basheer . is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Mandiyan Basheer . is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at ADAM AND EVE HEALTH SOLUTIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05318863.Mandiyan Basheer . is currently involved in 2 different roles. Their most recent position is with AISHAL MEDICITY PRIVATE LIMITED as a Individual Promoter. The first company Mandiyan Basheer . was appointed to as a director was ADAM AND EVE HEALTH SOLUTIONS PRIVATE LIMITED. Mandiyan Basheer . is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
2y 8m 1y 4m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ADAM AND EVE HEALTH SOLUTIONS PRIVATE LIMITED | Director | 16-Aug-2012 |
| AISHAL MEDICITY PRIVATE LIMITED | Individual Promoter | 31-Mar-2022 |
| AISHAL MEDICITY PRIVATE LIMITED | Director | 31-Mar-2022 |